HUTCHMED (China) Ltd Sustainability Reports
HUTCHMED (China) Limited is an innovative, commercial-stage biopharmaceutical company focused on the discovery, global development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases.
Sector: Manufacturing
Country: Hong Kong
Exchange: London Stock Exchange (AIM)
LEI: 2138006X34YDQ6OBYE79
FIGI: BBG001SQWWP6
15 reports from 2012 to 2025
